Hostname: page-component-89b8bd64d-5bvrz Total loading time: 0 Render date: 2026-05-09T08:42:00.408Z Has data issue: false hasContentIssue false

Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism

Published online by Cambridge University Press:  01 September 2007

José Lopez-Miranda
Affiliation:
Lipids and Atherosclerosis Research Unit, Department of Medicine. Hospital Universitario Reina Sofía, University of Cordoba, Córdoba, Spain
Christine Williams
Affiliation:
Hugh Sinclair Unit of Human Nutrition, School of Food Biosciences, University of Reading, 226 Whiteknights, Reading, Berkshire, RG6 6AP, UK
Denis Lairon*
Affiliation:
INSERM, 476 Nutrition Humaine et lipides, Marseille, F-13385 France; INRA, 1260, Marseille, F-13385 France; Université Méditerranée Aix-Marseille 2, Faculté de Médecine, IPHM-IFR 125, Marseille, F-13385France
*
*Corresponding author: Dr Denis Lairon, fax +33 4 91 78 21 01, email denis.lairon@medecine.univ-mrs.fr.
Rights & Permissions [Opens in a new window]

Abstract

Most of diurnal time is spent in a postprandial state due to successive meal intakes during the day. As long as the meals contain enough fat, a transient increase in triacylglycerolaemia and a change in lipoprotein pattern occurs. The extent and kinetics of such postprandial changes are highly variable and are modulated by numerous factors. This review focuses on factors affecting postprandial lipoprotein metabolism and genes, their variability and their relationship with intermediate phenotypes and risk of CHD. Postprandial lipoprotein metabolism is modulated by background dietary pattern as well as meal composition (fat amount and type, carbohydrate, protein, fibre, alcohol) and several lifestyle conditions (physical activity, tobacco use), physiological factors (age, gender, menopausal status) and pathological conditions (obesity, insulin resistance, diabetes mellitus). The roles of many genes have been explored in order to establish the possible implications of their variability in lipid metabolism and CHD risk. The postprandial lipid response has been shown to be modified by polymorphisms within the genes for apo A-I, A-IV, A-V, E, B, C-I and C-III, lipoprotein lipase, hepatic lipase, fatty acid binding and transport proteins, microsomal triglyceride transfer protein and scavenger receptor class B type I. Overall, the variability in postprandial response is important and complex, and the interactions between nutrients or dietary or meal compositions and gene variants need further investigation. The extent of present knowledge and needs for future studies are discussed in light of ongoing developments in nutrigenetics.

Information

Type
Research Article
Copyright
Copyright © The Authors 2007
Figure 0

Fig. 1 Human lipoprotein metabolism. Dietary free fatty acids (FFA) are absorbed from the gut and converted to triacylglycerols to be incorporated into chylomicrons in the intestinal epithelial cells. The triglyceride-rich apo B-48-containing chylomicrons enter the plasma via the intestinal lymph. Lipoprotein lipase (LPL) hydrolyses the triacylglycerol in chylomicrons to fatty acids, which are taken up by muscle cells for oxidation or adipocytes for storage. The remaining particles, the chylomicron remnants, are removed from the circulation by the liver through binding of their surface apo E to the LDL receptor or LDL receptor-related protein. VLDL particles are triacylglycerol-rich apo B-100-containing particles, synthesised by the liver. As with chylomicrons, VLDL triacylglycerols are hydrolysed by LPL. VLDL remnants or IDL are taken up by liver receptors via apo E or converted to LDL. Chylomicrons, VLDL and their respective remnants (remnant lipoproteins) are termed triacylglycerol-rich lipoproteins (TRL). Under physiological conditions, insulin, which is raised in the postprandial state, suppresses lipolysis from adipose tissue and hepatic VLDL production, but this insulin action is inappropriate in insulin resistance and type 2 diabetes, resulting in high TRL concentrations. The large amount of TRL and their prolonged residence time in the circulation increase the exchange of esterified cholesterol from HDL and LDL to TRL, and of triacylglycerols to LDL and HDL particles, which is mediated by cholesterol-ester transfer protein. Triacylglycerol enrichment of LDL particles renders them better substrates for hepatic lipase, which hydrolyses triacylglycerols from the core of LDL and turns them into smaller and denser particles. Small, dense LDL are more atherogenic as they readily enter the subendothelial space and become oxidised. Triacylglycerol-enriched HDL particles are smaller and are more rapidly catabolised, which may explain the observed low plasma HDL in insulin resistance and type 2 diabetes.

Figure 1

Table 1 Clinical trials summarizing the effect of postprandial lipoprotein metabolism on coronary artery disease (CAD)

Figure 2

Table 2 Clinical trials summarising the effect of postprandial lipoprotein metabolism on carotid artery atherosclerosis

Figure 3

Fig. 2 The effects of postprandial chylomicrons and VLDL on arterial endothelium. VLDL remnants and chylomicron remnants behave in much the same way as LDL. They enter the subendothelial space, where they become modified, and the modified remnants stimulate Chemoattractant protein-1 (MCP-1), promote the differentiation of monocytes into macrophages and are taken up by the macrophages to form foam cells. Like LDL, the remnant lipoproteins are proinflammatory and proatherogenic.

Figure 4

Table 3 Recent genetic association studies on postprandial lipoprotein response

Figure 5

Table 4 Factors affecting postprandial lipid metabolism